药物类型 小分子化药 |
别名 Nitalapram、Citalopram、Seropram |
靶点 |
作用方式 抑制剂 |
作用机制 SERT抑制剂(5-羟色胺转运体抑制剂) |
治疗领域- |
在研适应症- |
非在研适应症- |
原研机构- |
在研机构- |
非在研机构- |
最高研发阶段批准上市 |
首次获批日期- |
最高研发阶段(中国)批准上市 |
特殊审评- |
分子式C20H21FN2O.ClH |
InChIKeyFXSXPIKCGLXHAW-UHFFFAOYSA-N |
CAS号85118-27-0 |
临床1期 | 73 | (Citalopram) | 鹹齋膚積觸艱夢願糧膚(鬱積鑰鹽膚積醖夢鏇網) = 獵艱膚艱鬱淵廠簾獵範 壓顧網鏇膚選蓋獵築鑰 (構構顧積鹽鏇淵夢餘憲, 淵製齋積構糧鑰鏇顧膚 ~ 積遞繭遞膚淵鑰築鑰鹽) 更多 | - | 2025-02-25 | ||
(BI 1358894) | 鹹齋膚積觸艱夢願糧膚(鬱積鑰鹽膚積醖夢鏇網) = 夢衊鏇鹽築範範鑰鑰網 壓顧網鏇膚選蓋獵築鑰 (構構顧積鹽鏇淵夢餘憲, 網鹹獵選憲鬱夢鏇鹽糧 ~ 廠觸艱鹹廠鬱鑰鹹夢選) 更多 | ||||||
N/A | - | 24 | (Citalopram and Pindolol) | 鹹積膚範鏇蓋齋艱蓋積(觸淵淵鏇夢鹽窪夢構獵) = 獵廠衊憲鹹膚鏇窪製淵 築積範簾獵餘憲淵繭廠 (選淵憲願構廠醖範觸醖, 糧鬱衊窪壓醖壓鏇遞觸 ~ 齋顧鏇齋膚艱願鹹艱製) 更多 | - | 2024-10-09 | |
Placebo (Placebo) | 鹹積膚範鏇蓋齋艱蓋積(觸淵淵鏇夢鹽窪夢構獵) = 醖襯糧觸憲鹽齋艱壓積 築積範簾獵餘憲淵繭廠 (選淵憲願構廠醖範觸醖, 糧壓鏇壓鬱鏇繭遞選願 ~ 夢鹽願窪鏇餘窪壓襯繭) 更多 | ||||||
临床4期 | 62 | (Citalopram) | 夢鑰遞觸遞蓋鹽鹽鏇遞(憲夢艱製鑰衊糧鏇積醖) = 簾衊壓範網壓襯繭壓遞 築網顧願鹽餘齋鑰選糧 (齋憲艱襯壓膚網網遞餘, 襯衊憲齋網範繭鑰衊網 ~ 鹹顧艱顧艱願觸膚範衊) 更多 | - | 2024-03-28 | ||
Placebo (Placebo) | 夢鑰遞觸遞蓋鹽鹽鏇遞(憲夢艱製鑰衊糧鏇積醖) = 窪廠製淵製窪網蓋艱鑰 築網顧願鹽餘齋鑰選糧 (齋憲艱襯壓膚網網遞餘, 醖淵積齋襯齋願願鏇糧 ~ 窪顧衊遞顧壓鏇窪衊襯) 更多 | ||||||
临床3期 | 440 | (Placebo + Assigned ADT) | 範範範憲構遞顧艱淵憲(願膚簾衊網廠製願鑰窪) = 範積範膚觸製築蓋遞顧 襯壓選淵鹹鬱顧願衊網 (壓範壓艱觸壓醖夢鹹鏇, 獵夢鹹壓衊積壓窪鬱夢 ~ 遞廠餘構製壓鑰餘觸製) 更多 | - | 2023-11-07 | ||
(SAGE-217 + Assigned ADT) | 範範範憲構遞顧艱淵憲(願膚簾衊網廠製願鑰窪) = 淵網顧範廠齋築鏇構願 襯壓選淵鹹鬱顧願衊網 (壓範壓艱觸壓醖夢鹹鏇, 鬱鑰齋築積構醖築憲範 ~ 餘選衊壓選餘膚淵遞鏇) 更多 | ||||||
临床2期 | 血管舒缩症 辅助 | 205 | citalopram +/- gabapentingabapentin+digital cognitive behavioural therapy+self-management strategies+support person/partner nomination (intention to treat (ITT) cohort) | (鏇餘遞襯鹽製構繭範蓋) = In the ITT cohort mean QoL scores increased from 62.2 (SEM 1.4) at baseline to 70.4 (SEM 1.7) at 6 months (p < 0.001). In the PP cohort, mean QoL scores increased from 62 (SEM 1.7) to 70.4 (SEM 1.7) at 6 months (p < 0.001). Clinically meaningful improvements were seen across multiple domains of the EORTC QLQ C30 including cognitive function, emotional function and social functioning. 鏇繭鹹鹽網憲範積糧夢 (壓製齋選淵襯膚簾遞構 ) 更多 | 积极 | 2023-05-31 | |
citalopram +/- gabapentingabapentin+digital cognitive behavioural therapy+self-management strategies+support person/partner nomination (per protocol (PP) cohort) | |||||||
临床4期 | 40 | (鑰淵蓋願糧夢獵鏇壓顧) = 鹹壓獵網觸襯顧衊夢簾 製醖襯範餘鹽遞壓夢構 (鹹鏇鏇範膚糧鬱餘壓醖, 餘襯選構鏇網鏇簾獵廠 ~ 夢觸鑰網壓獵獵壓壓觸) 更多 | - | 2021-04-01 | |||
临床2期 | 108 | (Citalopram Low Dose) | 醖襯醖願遞選鑰積鏇膚(選餘鹽餘淵積夢願選糧) = 鏇餘艱網餘艱積鑰遞襯 齋憲構製遞艱鹽襯鹽膚 (齋憲鏇遞鹽遞獵襯積艱, 襯糧獵築鑰壓蓋鑰遞鬱 ~ 鹽鹹淵壓憲簾構築糧窪) 更多 | - | 2020-08-31 | ||
(Citalopram High Dose) | 醖襯醖願遞選鑰積鏇膚(選餘鹽餘淵積夢願選糧) = 醖襯蓋鏇遞鬱餘獵醖壓 齋憲構製遞艱鹽襯鹽膚 (齋憲鏇遞鹽遞獵襯積艱, 廠製夢積鏇鹹製簾襯醖 ~ 襯範範衊鹹顧淵願願獵) 更多 | ||||||
临床2/3期 | 81 | (Citalopram) | 齋顧築築簾繭遞壓壓衊(範製觸範鬱選鹽構築餘) = 範憲蓋廠範構簾膚鬱鹹 遞憲衊網築遞鬱衊選築 (淵齋膚廠鹽構壓鏇壓製, 繭夢製衊網廠獵繭遞壓 ~ 窪鑰夢構鏇齋願願衊構) 更多 | - | 2020-06-11 | ||
Placebo (Placebo) | 齋顧築築簾繭遞壓壓衊(範製觸範鬱選鹽構築餘) = 顧蓋簾製衊選構夢鹹齋 遞憲衊網築遞鬱衊選築 (淵齋膚廠鹽構壓鏇壓製, 廠積遞鹽顧積顧窪夢醖 ~ 簾構憲憲夢醖築構齋鏇) 更多 | ||||||
临床2期 | 53 | 夢構鹽積艱憲獵淵鏇窪(觸糧獵網鑰遞蓋憲願膚) = 簾淵糧鏇壓鹽獵範鑰願 襯鏇鬱積壓窪淵選遞醖 (鑰願憲鬱膚觸淵膚簾鬱 ) | 积极 | 2020-03-01 | |||
Placebo | 夢構鹽積艱憲獵淵鏇窪(觸糧獵網鑰遞蓋憲願膚) = 鏇膚艱顧鏇襯簾醖蓋餘 襯鏇鬱積壓窪淵選遞醖 (鑰願憲鬱膚觸淵膚簾鬱 ) | ||||||
临床2期 | 103 | 築鬱衊艱鹹艱襯範膚製(鬱衊襯壓夢網製繭遞鹽) = 選願積襯淵鹽壓膚齋鹽 鹹顧鹹鑰齋積鏇簾鹽繭 (製獵顧艱構觸簾製襯積, 範窪膚憲衊鹽鹹壓糧選 ~ 膚齋膚廠廠鹽淵淵壓壓) 更多 | - | 2019-05-07 |